FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3812311000001108: Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17827901000001113 Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17828001000001110 Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Is a Octreotide 100micrograms/mL injection solution 1mL ampule false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient Somatostatin false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient Octreotide false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient Synthetic hormone agent false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Is a Sandostatin true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Is a Octreotide 100micrograms/1ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Is a Octreotide 100micrograms/1ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Is pack of False Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has AMP True Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start